Healthy body cells grow, divide and die in an orderly and regulated fashion. Cancer is the result of unregulated cell proliferation. While there are various types of cancer, all are characterized by out-of-control cell growth.

When treating cancer, the critical challenge facing physicians is how to destroy the abnormal cells while minimizing the effects on healthy normal cells.

Healthy nonmalignant cells are relatively resistant to the "Trojan Horse" targeted vectors JARI is utilizing, resulting in improved therapeutic efficacy and reduced side effects for the patient.

We're dedicated to the development of cutting-edge cancer treatments that extend the quality and length of the lives of individuals with cancer.

Research has been conducted to diagnose tumors in animals and humans. The results were promising, showing significant uptake in tumors and no toxicity.

JARI is working in parallel studies to continue patented research into the possibility of combining vectors with other radiotherapy and chemotherapy treatments. This research could one day lead to additional breakthrough treatments for cancer.

JARI partners with the top medical Institutions in the world to form a powerful force for medical innovation. The collective insights and knowledge improve the potential for medical science breakthroughs and can translate scientific discoveries in the laboratory into leading-edge treatments and therapies for patients faster than less integrated medical practices.